Interim Results from the Phase 1B and Phase 2 TORREY Open-label Extension Study of Seralutinib in Pulmonary Arterial Hypertension (PAH)
O. Sitbon,S. Sahay,P. Escribano Subias, R. L. Zolty, J. F. Kingrey, B. Penn, I. Sobol,N. Sood,R. L. Benza,R. N. Channick,K. M. Chin,R. P. Frantz,A. R. Hemnes,L. S. Howard,V. V. Mclaughlin,J. Vachiery,R. T. Zamanian,M. Cravets,R. F. Roscigno,D. Mottola,E. Parsley,R. Aranda,L. S. Zisman,H. Ghofrani AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2024）
AI 理解论文
溯源树
样例
